Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Antiserum, Rocky Mountain Spotted Fever

FDA product code GPP · 1 cleared devices

Class 1 Microbiology
Regulation
21 CFR 866.3500
Review panel
MI
Implant
No
Life sustaining
No
Third party review
No
GMP exempt
No
Clearance span
1985-01-04 – 1985-01-04
↑